Legal Representation
Attorney
AnneMarie Kaiser
USPTO Deadlines
Application History
30 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 18, 2016 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Apr 18, 2016 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Sep 1, 2015 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
Aug 29, 2015 | EX5G | S | SOU EXTENSION 5 GRANTED |
Aug 21, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 21, 2015 | EXT5 | S | SOU EXTENSION 5 FILED |
Mar 19, 2015 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
Mar 18, 2015 | EX4G | S | SOU EXTENSION 4 GRANTED |
Mar 2, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Mar 2, 2015 | EXT4 | S | SOU EXTENSION 4 FILED |
Sep 25, 2014 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
Sep 24, 2014 | EX3G | S | SOU EXTENSION 3 GRANTED |
Sep 9, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Sep 9, 2014 | EXT3 | S | SOU EXTENSION 3 FILED |
Mar 19, 2014 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
Mar 18, 2014 | EX2G | S | SOU EXTENSION 2 GRANTED |
Feb 26, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 26, 2014 | EXT2 | S | SOU EXTENSION 2 FILED |
Oct 23, 2013 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
Oct 22, 2013 | EX1G | S | SOU EXTENSION 1 GRANTED |
Oct 11, 2013 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Sep 11, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Sep 11, 2013 | EXT1 | S | SOU EXTENSION 1 FILED |
Mar 12, 2013 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Jan 15, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION |
Dec 26, 2012 | NPUB | O | NOTICE OF PUBLICATION |
Dec 4, 2012 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 4, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Aug 27, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Aug 21, 2012 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Conducting research and clinical trials relating to medical devices in the field of cardiovascular disease
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042